New pill takes on deadly brain cancer in early trial
Disease control
Recruiting now
This early-phase study tests an experimental oral drug called GLIX1 in 30 adults whose aggressive brain tumor (high-grade glioma) has come back or worsened after standard treatments. The main goals are to find a safe dose and check for any signs that the drug can control the dise…
Phase: PHASE1 • Sponsor: Tetragon Biosciences Ltd • Aim: Disease control
Last updated May 04, 2026 16:19 UTC